Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Published: February 2010

Open Access Gateway

Intravascular Papillary Endothelial Hyperplasia (Masson’s Tumor) of the Mouth – A Case Report

Bologna-Molina R.a · Amezcua-Rosas G.b · Guardado-Luevanos I.c · Mendoza-Roaf P.L.a · González-Montemayor T.a · Molina-Frechero N.d

Author affiliations

aInstitute of Dental Research, Health Sciences University Center, Universidad de Guadalajara, bDermatological Institute of Jalisco ‘Dr. José Barba Rubio’, cUniversidad Guadalajara Lamar, and dHealth Care Department, Universidad Autónoma Metropolitana, México, México

Corresponding Author

Ronell Bologna-Molina

Paseo de las Galias 169

Colonia Lomas Estrella

México, DF 09890 (México)

Tel./Fax +52 55 5695 2916, E-Mail ronellbologna@hotmail.com

Related Articles for ""

Case Rep Dermatol 2010;2:22–26

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


We report a rare case of intravascular papillary endothelial hyperplasia (IPEH) of the oral mucosa. This neoplasm, known as Masson’s tumor, is an unusual vascular lesion of proliferating endothelial cells. It is usually confined to the lumen of preexisting vessels or vascular malformations. The principal significance of IPEH is its microscopic resemblance to angiosarcoma and possible misdiagnosis as such. Achieving a correct diagnosis is essential to avoid subjecting a patient to unnecessarily aggressive therapy. For this reason, awareness of this lesion is very important for dermatologists and dentists. In this article, we discuss the clinical features, histopathological characteristics, and management of IPEH and review the pertinent literature.

© 2010 S. Karger AG, Basel

Article / Publication Details

First-Page Preview
Abstract of Published: February 2010

Published online: February 06, 2010
Issue release date: January – April

Number of Print Pages: 5
Number of Figures: 2
Number of Tables: 0

eISSN: 1662-6567 (Online)

For additional information: https://www.karger.com/CDE

Open Access License / Drug Dosage / Disclaimer

Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.